Skip to main content
Screener/Healthcare/Biotechnology

ATRA — Atara Biotherapeutics, Inc.

NASDAQ
$9.70-0.27 (-2.71%)
Under $10Healthcare
$3.92
$19.14
$9.21
$10.06
EPS (TTM)$-0.67
P/E Ratio2.96
Dividend Yield—
Market Cap$40.8M
Volume110K
Prev Close$9.96
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q1 '26$516K-$4.1M$-0.2976.0%-803.3%
Q4 '25$1.6M-$3.4M$-0.2593.5%-213.5%
Q3 '25$3.5M-$4.3M$-0.3296.7%-124.6%
Q2 '25$17.6M$2.4M$0.1996.8%13.6%
Q1 '25$98.1M$38.0M$3.5079.2%38.7%
Q4 '24$32.8M-$12.7M$-1.1979.3%-38.8%
Q3 '24$40.2M-$21.9M$-2.9381.1%-54.5%
Q2 '24$28.6M-$19.0M$-3.1083.8%-66.5%
Get Your Daily Market Recap